Issue Price
₹125
Per Share
GMP
NIL
Grey Market
Est. Listing
₹125
Expected Price
Min. Application
₹250,000
2 lots × 1000 shares
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.Competitive Strengths:Trusted, high quality, and reliable brand name.Customer-centric approach & servicesLocation benefitsWide range of diagnostic services at affordable pricesRobust IT technical capabilities with strong IT infrastructureStrong and experienced leadership with a dedicated management team
Nidan Laboratories & Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 200,000 | — | ₹2.50 Cr | — |
| TOTAL | 4,000,000 | 100.00% | ₹50.00 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹125,000 |
| Retail (Max) | 13 | 13,000 | ₹1,625,000 |
| sNII (Min) | 14 | 14,000 | ₹1,750,000 |
| bNII (Min) | 68 | 68,000 | ₹8,500,000 |
| Particulars | 30-Jun-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue from Operations | 7.85 | 21.85 | 22.19 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 1.09 | 2.30 | 0.71 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 54.33 | 52.44 | 45.21 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |